Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 4
2005 9
2006 4
2007 2
2008 2
2009 6
2010 6
2011 6
2012 8
2013 7
2014 2
2015 7
2016 3
2017 2
2018 5
2019 3
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

68 results
Results by year
Filters applied: . Clear all
Page 1
Pharmacological inhibition of bacterial β-glucuronidase prevents irinotecan-induced diarrhea without impairing its antitumor efficacy in vivo.
Cheng KW, Tseng CH, Tzeng CC, Leu YL, Cheng TC, Wang JY, Chang JM, Lu YC, Cheng CM, Chen IJ, Cheng YA, Chen YL, Cheng TL. Cheng KW, et al. Among authors: tzeng cc. Pharmacol Res. 2019 Jan;139:41-49. doi: 10.1016/j.phrs.2018.10.029. Epub 2018 Nov 1. Pharmacol Res. 2019. PMID: 30391354
A novel NOX2 inhibitor attenuates human neutrophil oxidative stress and ameliorates inflammatory arthritis in mice.
Liu FC, Yu HP, Chen PJ, Yang HW, Chang SH, Tzeng CC, Cheng WJ, Chen YR, Chen YL, Hwang TL. Liu FC, et al. Among authors: tzeng cc. Redox Biol. 2019 Sep;26:101273. doi: 10.1016/j.redox.2019.101273. Epub 2019 Jul 10. Redox Biol. 2019. PMID: 31325723 Free PMC article.
Discovery of 3-Amino-2-Hydroxypropoxyisoflavone Derivatives as Potential Anti-HCV Agents.
Lee JC, Lin CK, Tseng CK, Chen YL, Tzeng CC, Tseng CH. Lee JC, et al. Among authors: tzeng cc. Molecules. 2018 Nov 2;23(11):2863. doi: 10.3390/molecules23112863. Molecules. 2018. PMID: 30400244 Free PMC article.
Novel CIL-102 derivatives as potential therapeutic agents for docetaxel-resistant prostate cancer.
Miller DR, Tzeng CC, Farmer T, Keller ET, Caplan S, Chen YS, Chen YL, Lin MF. Miller DR, et al. Among authors: tzeng cc. Cancer Lett. 2018 Nov 1;436:96-108. doi: 10.1016/j.canlet.2018.07.039. Epub 2018 Aug 3. Cancer Lett. 2018. PMID: 30077739 Free PMC article.
Discovery of Pyrazolo[4,3-c]quinolines Derivatives as Potential Anti-Inflammatory Agents through Inhibiting of NO Production.
Tseng CH, Tung CW, Peng SI, Chen YL, Tzeng CC, Cheng CM. Tseng CH, et al. Among authors: tzeng cc. Molecules. 2018 Apr 28;23(5):1036. doi: 10.3390/molecules23051036. Molecules. 2018. PMID: 29710774 Free PMC article.
Discovery of 2-Substituted 3-Arylquinoline Derivatives as Potential Anti-Inflammatory Agents Through Inhibition of LPS-Induced Inflammatory Responses in Macrophages.
Yang CY, Hung YL, Tang KW, Wang SC, Tseng CH, Tzeng CC, Liu PL, Li CY, Chen YL. Yang CY, et al. Among authors: tzeng cc. Molecules. 2019 Mar 23;24(6):1162. doi: 10.3390/molecules24061162. Molecules. 2019. PMID: 30909606 Free PMC article.
Discovery of Indeno[1,2-c]quinoline Derivatives as Potent Dual Antituberculosis and Anti-Inflammatory Agents.
Tseng CH, Tung CW, Wu CH, Tzeng CC, Chen YH, Hwang TL, Chen YL. Tseng CH, et al. Among authors: tzeng cc. Molecules. 2017 Jun 16;22(6):1001. doi: 10.3390/molecules22061001. Molecules. 2017. PMID: 28621733 Free PMC article.
Specific Inhibition of Bacterial β-Glucuronidase by Pyrazolo[4,3-c]quinoline Derivatives via a pH-Dependent Manner To Suppress Chemotherapy-Induced Intestinal Toxicity.
Cheng KW, Tseng CH, Yang CN, Tzeng CC, Cheng TC, Leu YL, Chuang YC, Wang JY, Lu YC, Chen YL, Cheng TL. Cheng KW, et al. Among authors: tzeng cc. J Med Chem. 2017 Nov 22;60(22):9222-9238. doi: 10.1021/acs.jmedchem.7b00963. Epub 2017 Nov 9. J Med Chem. 2017. PMID: 29120626
Discovery of indeno[1,2-b]quinoxaline derivatives as potential anticancer agents.
Tseng CH, Chen YR, Tzeng CC, Liu W, Chou CK, Chiu CC, Chen YL. Tseng CH, et al. Among authors: tzeng cc. Eur J Med Chem. 2016 Jan 27;108:258-273. doi: 10.1016/j.ejmech.2015.11.031. Epub 2015 Nov 24. Eur J Med Chem. 2016. PMID: 26686931
68 results
Jump to page
Feedback